Who are Micro-particle Curcumin's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/micro-particle-curcumin.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Micro-particle Curcumin — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Micro-particle Curcumin (Micro-particle Curcumin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Natural product derivative / Anti-inflammatory agent. Area: Inflammatory diseases / Oncology.

phase 3 Natural product derivative / Anti-inflammatory agent Inflammatory diseases / Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Micro-particle Curcumin (Micro-particle Curcumin) — London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's. Micro-particle curcumin is a formulation of the natural polyphenol curcumin designed to improve bioavailability and enhance anti-inflammatory and antioxidant effects in the body.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Micro-particle Curcumin TARGET	Micro-particle Curcumin	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	phase 3	Natural product derivative / Anti-inflammatory agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Natural product derivative / Anti-inflammatory agent class)

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Micro-particle Curcumin — Competitive Intelligence Brief. https://druglandscape.com/ci/micro-particle-curcumin. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing